| Citation: | WANG Xiaohua, WANG Jun, LI Li, GAO Qian. Diagnostic value of ESM-1 and PTX3 in elderly patients with diabetic nephropathy complicated with pulmonary infection[J]. Chinese Journal of General Practice, 2025, 23(8): 1333-1336. doi: 10.16766/j.cnki.issn.1674-4152.004127 |
| [1] |
LI X, LU L H, HOU W T, et al. Epigenetics in the pathogenesis of diabetic nephropathy[J]. Acta Biochim Biophys Sin(Shanghai), 2022, 54(2): 163-172.
|
| [2] |
李温柳, 邢春燕, 李勤, 等. 雷公藤多苷治疗糖尿病肾病1例及抗炎抗纤维化疗效分析[J]. 中华全科医学, 2024, 22(3): 530-533. doi: 10.16766/j.cnki.issn.1674-4152.003442
LI W L, XING C Y, LI Q, et al. Tripterygium glycosides in the treatment of diabetic nephropathy: a case report and analysis of anti-inflammatory and anti-fibrotic efficacy[J]. Chinese Journal of General Practice, 2024, 22(3): 530-533. doi: 10.16766/j.cnki.issn.1674-4152.003442
|
| [3] |
CONSTANTIN L, UNGURIANU A, STREINU-CERCEL A, et al. Investigation of serum endocan levels in SARS-CoV-2 patients[J]. Int J Mol Sci, 2024, 25(5): 3042-3056. doi: 10.3390/ijms25053042
|
| [4] |
郭俊, 许强宏. 脓毒症患者血栓调节蛋白和纤溶酶原激活物抑制剂-1及内皮细胞损伤程度的研究初探[J]. 中华内科杂志, 2021, 60(2): 143-146.
GUO J, XU Q H. Thrombomodulin, plasminogen activator inhibitor-1, and endothelial injury severity in sepsis patients: a preliminary study[J]. Chinese Journal of Internal Medicine, 2021, 60(2): 143-146.
|
| [5] |
KERGET F, KERGET B, KAHRAMAN Ç Y, et al. Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19[J]. J Med Virol, 2021, 93(12): 6653-6659. doi: 10.1002/jmv.27238
|
| [6] |
DOBIÁS R, JAWORSKÁ P, SKOPELIDOU V, et al. Distinguishing invasive from chronic pulmonary infections: host pentraxin 3 and fungal siderophores in bronchoalveolar lavage fluids[J]. J Fungi (Basel), 2022, 8(11): 1194-1204.
|
| [7] |
中华医学会内分泌学分会. 中国成人糖尿病肾脏病临床诊断的专家共识[J]. 中华内分泌代谢杂志, 2016, 31(10): 379-385.
Chinese Society of Endocrinology. Expert consensus on the clinical diagnosis of diabetic kidney disease in chinese adults[J]. Chinese Journal of Endocrinology and Metabolism, 2016, 31(10): 379-385.
|
| [8] |
中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志, 2001, 81(5): 314-320.
Ministry of Health of the People's Republic of China. Diagnostic criteria for hospital-acquired infections (trial implementation)[J]. Chinese Medical Journal, 2001, 81(5): 314-320.
|
| [9] |
HUREAU M, PORTIER L, PRIN M, et al. Evaluation of endocan as a treatment for acute inflammatory respiratory failure[J]. Cells, 2023, 12(2): 257-268. doi: 10.3390/cells12020257
|
| [10] |
GÖRGÜN S, CINDORUK Ş, ÖZGEN E, et al. Diagnostic and prognostic value of serum endocan levels in patients with COVID-19[J]. Angiology, 2021, 72(10): 942-946. doi: 10.1177/00033197211026044
|
| [11] |
SHARMA A, AGRAWAL A, SINDHWANI G, et al. Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions[J]. Pleura Peritoneum, 2021, 6(2): 83-90. doi: 10.1515/pp-2021-0111
|
| [12] |
LI J, LI Y, CHAI R F, et al. PTX3 protects intestinal mucosal barrier damage in sepsis through toll-like receptor signaling pathway[J]. Inflammation, 2022, 45(6): 2339-2351. doi: 10.1007/s10753-022-01696-z
|
| [13] |
ZHAO C, ZHAO X S, XU L P, et al. Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study[J]. BMC Infect Dis, 2022, 22(1): 292-302. doi: 10.1186/s12879-022-07298-2
|
| [14] |
裴戌锋, 严友纪, 黄芳, 等. 血清ESM-1、VE-Cad、CC16水平与脓毒症并发急性呼吸窘迫综合征患者炎性因子及预后的关系研究[J]. 现代生物医学进展, 2022, 22(13): 2570-2574.
PEI X F, YAN Y J, HUANG F, et al. Relationship between serum ESM-1, VE-Cad, CC16 levels and inflammatory factors as well as prognosis in sepsis patients complicated with acute respiratory distress syndrome[J]. Progress in Modern Biomedicine, 2022, 22(13): 2570-2574.
|
| [15] |
SHI G Q, YANG L, SHAN L Y, et al. Investigation of the clinical significance of detecting PTX3 for community-acquired pneumonia[J]. Eur Rev Med Pharmacol Sci, 2020, 24(16): 8477-8482.
|
| [16] |
杜静, 赵华昌, 李小燕, 等. SM-1、IFN-γ、IL-1β与IL-8对ARDS合并肺部感染及预后的预测价值[J]. 中华医院感染学杂志, 2023, 33(19): 2886-2890.
DU J, ZHAO H C, LI X Y, et al. Predictive value of SM-1, IFN-γ, IL-1β, and IL-8 in ARDS complicated with pulmonary infection and prognosis[J]. Chinese Journal of Nosocomiology, 2023, 33(19): 2886-2890.
|
| [17] |
田茜, 李宝新, 李娜, 等. 2型糖尿病肾脏病患者血清长正五聚蛋白3和α-klotho蛋白水平的变化及意义[J]. 安徽医学, 2020, 41(8): 900-906.
TIAN Q, LI BX, LI N, et al. Changes and clinical significance of serum long pentraxin 3 and alpha-klotho protein levels in patients with type 2 diabetic kidney disease[J]. Anhui Medical Journal, 2020, 41(8): 900-906.
|
| [18] |
IN E, KULUÖZTÜRK M, TURGUT T, et al. Endocan as a potential biomarker of disease severity and exacerbations in COPD[J]. Clin Respir J, 2021, 15(4): 445-453. doi: 10.1111/crj.13320
|
| [19] |
HE Q, ZHANG M, FENG C L. The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis[J]. BMC Pulm Med, 2021, 21(1): 414-419. doi: 10.1186/s12890-021-01793-z
|
| [20] |
TANG S C W, YIU W H. Innate immunity in diabetic kidney disease[J]. Nat Rev Nephrol, 2020, 16(4): 206-222. doi: 10.1038/s41581-019-0234-4
|
| [21] |
赵自然, 王峥, 董朋涛, 等. Klotho在糖尿病肾病中调控机制研究进展[J]. 中华实用诊断与治疗杂志, 2024, 38(10): 1077-1080.
ZHAO Z R, WANG Z, DONG P T, et al. Research Progress on the Regulatory Mechanism of Klotho in Diabetic Nephropathy[J]. Chinese Journal of Practical Diagnosis and Treatment, 2024, 38(10): 1077-1080.
|
| [22] |
马婷婷, 刘莉, 徐萍, 等. 达格列净对糖尿病肾病患者肾功能及miR-21-5p和miR-423-5p水平的影响[J]. 中国临床研究, 2024, 37(8): 1219-1223.
MA T T, LIU L, XU P, et al. Effects of dapagliflozin on renal function and levels of miR-21-5p and miR-423-5p in patients with diabetic nephropathy[J]. Chinese Clinical Research, 2024, 37(8): 1219-1223
|